Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd ARDS Drug Development Summit 2022

Evvnt Promotion / evvnt
-
13.07.2022 - 15.07.2022  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 09:00 - 16:15
 
Temi della conferenza
Acute Respiratory Distress Syndrome (ARDS) is a growing and concerning unmet medical need with no effective therapeutic, and a serious medical burden in a world with or without COVID-19. Bringing industry together to consolidate the last 18 months of clinical and translational data, the 2nd ARDS Drug Development Summit is the only translational conference for drug developers to leverage the large homogeneous populations of COVID ARDS.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Alistair Wheeler, Chief Medical Officer, BioMarck Pharmaceuticals, Alpha A. Fowler, Professor, Virginia University, Aurelia De Pauw, Senior Vice President - Clinical Programs and Medical Affairs, Tetra Bio-Pharma and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1034443-1?pid=4832
Ms. Jessica Durston
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2199.0 - USD 4297.0
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceHelix - Forschung & Beratung WienCharité International AcademyÖsterreichische Akademie der ÄrzteEuropean Public Health Association (EUPHA)AMREF - African Medical and Research FoundationÖsterreichische Gesellschaft für Public HealthAGEM - Arbeitsgemeinschaft Ethnologie und Medizin